Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.76 HKD | -19.09% | -19.09% | -34.95% |
Mar. 28 | Ascentage Pharma Widens Loss by Nearly 5% in 2023 | MT |
Mar. 27 | Ascentage Pharma Group International Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.95% | 798M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock Ascentage Pharma Group International - Hong Kong S.E.
- News Ascentage Pharma Group International
- Ascentage Pharma Group Gets Canadian Approval for Leukemia Treatment Phase 1B Study